Abstract
Santhera Pharmaceuticals, Pratteln, Switzerland Santhera Pharmaceuticals, Pratteln, Switzerland Department of Neurology, Friedrich-Baur-Institute, University Hospital of the Ludwig-Maximilians-University, Munich, Germany German Center for Neurodegenerative Diseases (DZNE), Munich, Germany Munich Cluster for Systems Neurology (SyNergy), Munich, Germany M. Silva, X. Llòria are regular employees of Santhera. T. Klopstock has received research support, consultancy fees, speaker honoraria and travel funds from GenSight Biologics, Chiesi GmbH and Santhera Pharmaceuticals, unrelated to this paper. Neither physicians nor authors received funding for managing patients, collecting data or write the paper. Statistical analysis was funded by Santhera Pharmaceuticals.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
